Senior Director, Early Differentiation & Pipeline Strategy, Oncology

Bristol Myers Squibb

. Own global medical strategy for a subset of hematology and oncology early-development assets from candidate selection through clinical proof-of-concept .

Posted 9/29/2026full-timePrinceton • New Jersey • United StatesSenior💰 $229,380 - $277,956 per yearWebsite

Core Competencies

Role fit

Core Competencies

Use this summary to align your resume positioning with the role.

Demonstrates expertise in Medical Affairs and Clinical Development with a focus on hematology and oncology, leveraging advanced degrees and extensive experience to drive innovative data generation and strategic medical communications.

Highest-signal resume keywords

Advanced Degree - MD, PharmD, or PhD8-10 Years Clinical or Medical ExperienceMedical Affairs ExperienceHematology and Oncology Therapeutic ExperienceExcellent Communication Skills

ATS Keywords

Tailor your resume

Applicant Tracking System Keywords

Tip: use these terms in your resume and cover letter to boost ATS matches.

Hard Skills

Clinical DevelopmentTranslational MedicineTarget Product ProfilesIntegrated Evidence PlansScientific NarrativesPublication StrategiesData GenerationComplex Scientific Synthesis

Soft Skills

Ability to Influence StakeholdersLeadership Without AuthorityCross-Functional Relationship ManagementMatrixed Environment Navigation

Industry Keywords

HematologyOncologyPharma IndustryThought Leader EngagementAdvisory Board Planning

About the role

Key responsibilities & impact

Own global medical strategy for a subset of hematology and oncology early-development assets from candidate selection through clinical proof-of-concept
Provide medical accountability for a set of early HO assets
Manage cross-functional relationships across R&D, Medical, and Commercial teams
Serve as a core member of early asset Global Program Teams
Partner with Global Program Leads, Clinical Development leads, Translational Medicine leads, and HO Medical/Commercial teams to deliver program objectives and milestones
Ensure development of differentiated early Target Product Profiles and contribute to early Clinical Development Plans
Own early Integrated Evidence Plans to drive innovative data generation and accelerate and de-risk clinical development
Own medical communications strategies and develop scientific narratives and publication strategies
Engage external Thought Leaders and Patient Advocacy groups to inform compound strategies, asset decisions, and portfolio tradeoffs
Lead planning and execution of advisory boards
Work effectively in a highly matrixed environment with an enterprise mindset

Requirements

What you’ll need

Advanced degree - MD, PharmD, or PhD
8-10 years clinical, medical, or other pharma industry experience
Relevant industry experience in Medical Affairs, Translational Medicine, and/or Clinical Development
Therapeutic experience in malignant hematology and/or oncology
Working knowledge of basic and clinical science and early drug development
Proven ability to interact with thought leaders and key customers in the early clinical space
Ability to manage multiple assets, priorities, and decision timelines in a complex, matrixed environment
Ability to lead without direct authority
Excellent communication skills
Ability to synthesize complex scientific and clinical information and construct compelling value narratives
Ability to influence and align diverse stakeholders

Benefits

Comp & perks

Comprehensive wellbeing support, retirement and financial protection benefits
Medical, dental, vision, life and disability insurance offerings
Flexible Time Off (FTO) without a set accrual limit for eligible U.S.-based exempt employees
11 paid company holidays each year
160 hours of paid vacation annually for eligible new hires
3 optional holidays for eligible employees
Paid sick leave
Up to two paid volunteer days per year
Summer hours flexibility
Medical, personal, parental, caregiver, bereavement, or military leaves of absence
Annual Global Shutdown between Christmas Day and New Year's Day
Additional discretionary incentive cash and stock opportunities
Workplace accommodations/adjustments and ongoing support for people with disabilities